Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» psoriasis
psoriasis
Novartis touts 5-year Cosentyx data as it works to hold top spot in psoriasis
Fierce Pharma
Wed, 09/13/17 - 09:43 pm
Novartis
Cosentyx
psoriasis
Dr. Reddy's sells off psoriasis candidate in out-licensing deal
BioPharma Dive
Wed, 08/23/17 - 10:04 pm
Dr Reddy's
psoriasis
out-licensing
DFD-06
Encore Dermatology
J&J's Tremfya approved, further crowding IL-inhibitor market
BioPharma Dive
Sat, 07/15/17 - 11:31 am
JNJ
Tremfya
psoriasis
Interleukin-inhibitors
guselkumab
FDA clears Philips' light therapy wearable for mild psoriasis
Fierce Biotech
Sat, 07/15/17 - 11:16 am
FDA
devices
Philips
psoriasis
BlueControl
light therapy
J&J gets a quick FDA OK for its blockbuster psoriasis contender guselkumab
Endpoints
Thu, 07/13/17 - 05:38 pm
JNJ
FDA
psoriasis
guselkumab
Will Low Pricing for Siliq Be Enough to Help Valeant Turn Things Around?
Motley Fool
Tue, 04/25/17 - 11:10 am
Valeant Pharmaceuticals
Siliq
drug pricing
brodalumab
psoriasis
AstraZeneca
Amgen
Black box warning? No worries, Valeant bills Siliq as the ‘low-cost’ psoriasis alternative to rivals from Novartis, Eli Lilly
Endpoints
Fri, 04/21/17 - 11:45 am
Valeant Pharmaceuticals
Siliq
black box
Eli Lilly
Novartis
psoriasis
How a $37,000-a-year medicine sets a good model for drug pricing
Stat
Tue, 04/4/17 - 12:17 am
drug pricing
psoriasis
Dupixent
Regeneron
Merck, Avillion ink development deal for nanobody psoriasis treatment
Mass Device
Fri, 03/31/17 - 09:49 am
Merck
Avillion
psoriasis
nanobodies
anti IL-17 A/F
Novartis’s Cosentyx Managed to Achieve Blockbuster Status in 2016
Market Realist
Wed, 03/29/17 - 09:31 am
Novartis
Cosentyx
psoriasis
J&J looks for the inside story with new online psoriasis campaign
Fierce Pharma
Tue, 03/28/17 - 10:54 am
JNJ
psoriasis
Janssen
drug marketing
Novartis star Cosentyx, facing new rivals, may gain edge as a disease-modifying med
Fierce Pharma
Tue, 03/21/17 - 10:00 am
Novartis
Cosentyx
psoriasis
Eli Lilly
Taltz
Valeant Pharmaceuticals
Siliq
Does Valeant have the ad dollars to keep Siliq competitive in psoriasis?
Fierce Pharma
Sat, 03/4/17 - 01:55 pm
Valeant Pharmaceuticals
Siliq
psoriasis
direct ads
DTC ads
J&J may be late to the psoriasis drug market party, but it’s planning to make a splash with guselkumab
Endpoints
Fri, 03/3/17 - 09:36 am
JNJ
psoriasis
guselkumab
Purdue Pharma Puts Skin In The Game With Psoriasis Deal
Seeking Alpha
Thu, 12/15/16 - 10:09 am
Purdue Pharma
psoriasis
AST-005
antisense
Exicure
Are DTC ads tipping the balance in psoriasis battle between Lilly’s Taltz and Novartis’ Cosentyx?
Fierce Pharma
Mon, 12/5/16 - 10:10 am
DTC advertising
psoriasis
Eli Lilly
Novartis
Taltz
Cosentyx
FDA OKs Expanded Use of Amgen's Enbrel
Investopedia
Thu, 11/10/16 - 10:18 am
FDA
Amgen
Enbrel
pediatrics
psoriasis
Eli Lilly’s new psoriasis treatment Taltz launches first ads, chasing Novartis’ Cosentyx lead
Fierce Pharma
Wed, 10/12/16 - 11:33 am
Eli Lilly
psoriasis
Novartis
Cosentyx
Taltz
drug ads
This Looks to Be Johnson & Johnson's Next Blockbuster Drug
Motley Fool
Wed, 10/5/16 - 09:40 am
JNJ
psoriasis
guselkumab
J&J psoriasis drug tops placebo, Humira in late stage study
Yahoo/Reuters
Mon, 10/3/16 - 09:42 pm
JNJ
psoriasis
Humira
AbbVie
guselkumab
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »